Prosperity Capital Advisors’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
Other funds holding PFE
CWP
FWIA
ORIO
CNB
KC
Prosperity Capital Advisors's PFE Position: Q2 2026 in Review
Prosperity Capital Advisors increased its Pfizer (PFE) stake by 8.4% in Q2 2026, buying an estimated $66.4K and bringing the position to 32,587 shares worth $785K. The position accounts for 0.04% of the portfolio, ranked #218.
Prosperity Capital Advisors first reported a position in PFE in Q4 2022 and has held it in 15 quarters since. The position peaked at $844K in Q1 2026. 632 funds tracked by Wall St. Rank hold PFE as of Q2 2026.
- Prosperity Capital Advisors held 32,587 shares of Pfizer worth $785K as of Q2 2026.
- Prosperity Capital Advisors bought 2,537 Pfizer shares in Q2 2026, an estimated $66.4K.
- Pfizer made up 0.04% of Prosperity Capital Advisors's portfolio in Q2 2026, its #218 holding.
- Prosperity Capital Advisors first reported a position in Pfizer in Q4 2022 and has held it in 15 quarters since.
- Prosperity Capital Advisors's Pfizer position peaked at $844K in Q1 2026.
- 632 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.
Based on Prosperity Capital Advisors's 13F filing for Q2 2026, filed 20 Jul 2026.